Artiva Biotherapeutics, Inc. (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

5.01

-0.15 (-2.91%)

At close: Mar 27, 2026, 4:00 PM EDT

5.04

+0.03 (0.60%)

After-hours: Mar 27, 2026, 6:41 PM EDT

Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	26.7	40.24	53.5	102.53	160.92
Short-Term Investments	81.31	145.19	23.47	-	-
Cash & Short-Term Investments	108.01	185.43	76.97	102.53	160.92
Cash Growth	-41.75%	140.91%	-24.93%	-36.29%	532.51%
Total Current Assets	108.01	185.43	76.97	102.53	160.92
Total Assets	108.01	185.43	76.97	102.53	160.92
Net Cash (Debt)	108.01	185.43	76.97	102.53	160.92
Net Cash Growth	-41.75%	140.91%	-24.93%	-36.29%	532.51%
Net Cash Per Share	4.42	16.47	95.89	133.73	0.23

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q